BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25712669)

  • 61. Src acts as the target of matrine to inhibit the proliferation of cancer cells by regulating phosphorylation signaling pathways.
    Zhang X; Xu H; Bi X; Hou G; Liu A; Zhao Y; Wang G; Cao X
    Cell Death Dis; 2021 Oct; 12(10):931. PubMed ID: 34642304
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo.
    Mohan CD; Bharathkumar H; Bulusu KC; Pandey V; Rangappa S; Fuchs JE; Shanmugam MK; Dai X; Li F; Deivasigamani A; Hui KM; Kumar AP; Lobie PE; Bender A; Basappa ; Sethi G; Rangappa KS
    J Biol Chem; 2014 Dec; 289(49):34296-307. PubMed ID: 25320076
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Matrine inhibits proliferation and induces apoptosis of human colon cancer LoVo cells by inactivating Akt pathway.
    Zhang S; Cheng B; Li H; Xu W; Zhai B; Pan S; Wang L; Liu M; Sun X
    Mol Biol Rep; 2014; 41(4):2101-8. PubMed ID: 24452711
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway.
    Li F; Rajendran P; Sethi G
    Br J Pharmacol; 2010 Oct; 161(3):541-54. PubMed ID: 20880395
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Matrine suppresses KRAS-driven pancreatic cancer growth by inhibiting autophagy-mediated energy metabolism.
    Cho YR; Lee JH; Kim JH; Lee SY; Yoo S; Jung MK; Kim SJ; Yoo HJ; Pack CG; Rho JK; Son J
    Mol Oncol; 2018 Jun; 12(7):1203-1215. PubMed ID: 29791786
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells.
    Ma L; Wen S; Zhan Y; He Y; Liu X; Jiang J
    Planta Med; 2008 Feb; 74(3):245-51. PubMed ID: 18283616
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
    Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
    World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Tan SM; Li F; Rajendran P; Kumar AP; Hui KM; Sethi G
    J Pharmacol Exp Ther; 2010 Jul; 334(1):285-93. PubMed ID: 20378717
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor.
    Muto A; Hori M; Sasaki Y; Saitoh A; Yasuda I; Maekawa T; Uchida T; Asakura K; Nakazato T; Kaneda T; Kizaki M; Ikeda Y; Yoshida T
    Mol Cancer Ther; 2007 Mar; 6(3):987-94. PubMed ID: 17363492
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Matrine activates PTEN to induce growth inhibition and apoptosis in V600EBRAF harboring melanoma cells.
    Jin H; Sun Y; Wang S; Cheng X
    Int J Mol Sci; 2013 Jul; 14(8):16040-57. PubMed ID: 23912239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Matrine induces apoptosis and autophagy in human lung adenocarcinoma cells via upregulation of Cavin3 and suppression of PI3K/AKT pathway.
    Wan Q; Du Z; Fang Z; Cheng H; Li C; Zhou X
    J BUON; 2020; 25(3):1512-1516. PubMed ID: 32862598
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of matrine on JAK2/STAT3 signaling pathway and brain protection in rats with cerebral ischemia-reperfusion.
    Chen J; Huang C; Ye L; Yao B; Yang M; Cai Q
    Adv Clin Exp Med; 2020 Aug; 29(8):959-966. PubMed ID: 32820869
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD).
    Zhang Z; Wang X; Wu W; Wang J; Wang Y; Wu X; Fei X; Li S; Zhang J; Dong P; Gu J; Liu Y
    Phytother Res; 2012 Jun; 26(6):932-7. PubMed ID: 22162124
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Research advances on anticancer activities of matrine and its derivatives: An updated overview.
    Rashid HU; Xu Y; Muhammad Y; Wang L; Jiang J
    Eur J Med Chem; 2019 Jan; 161():205-238. PubMed ID: 30359819
    [TBL] [Abstract][Full Text] [Related]  

  • 75. TAT-mediated delivery of neuroglobin attenuates apoptosis induced by oxygen-glucose deprivation via the Jak2/Stat3 pathway in vitro.
    Lin Y; Cai B; Xue XH; Fang L; Wu ZY; Wang N
    Neurol Res; 2015 Jun; 37(6):531-8. PubMed ID: 25023896
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Oxymatrine induces cell cycle arrest and apoptosis and suppresses the invasion of human glioblastoma cells through the EGFR/PI3K/Akt/mTOR signaling pathway and STAT3.
    Dai Z; Wang L; Wang X; Zhao B; Zhao W; Bhardwaj SS; Ye J; Yin Z; Zhang J; Zhao S
    Oncol Rep; 2018 Aug; 40(2):867-876. PubMed ID: 29989652
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A study on the inhibitory effect of matrine on gastric cancer SGC-7901 cells.
    Song S; Zhu S; Zhang Z; Mo Z; Ke Q; Luo Z
    Afr J Tradit Complement Altern Med; 2013; 10(6):435-8. PubMed ID: 24311863
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells.
    Lee DH; Sung KS; Bartlett DL; Kwon YT; Lee YJ
    Cell Signal; 2015 Feb; 27(2):293-305. PubMed ID: 25446253
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of matrine and oxymatrine on catalytic activity of cytochrome p450s in rats.
    Yuan F; Chen J; Wu WJ; Chen SZ; Wang XD; Su Z; Huang M
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):906-13. PubMed ID: 20524938
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Matrine alleviates AGEs- induced cardiac dysfunctions by attenuating calcium overload via reducing ryanodine receptor 2 activity.
    Wang J; Tang Z; Zhang Y; Qiu C; Zhu L; Zhao N; Liu Z
    Eur J Pharmacol; 2019 Jan; 842():118-124. PubMed ID: 30339815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.